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Theoretical investigation of measuring cerebral blood
flow in the adult human head using bolus Indocyanine
Green injection and near-infrared spectroscopy
Terence S. Leung, Ilias Tachtsidis, Martin Tisdall, Martin Smith, David T. Delpy, and Clare E. Elwell
To investigate the accuracy of measuring cerebral blood flow (CBF) using a bolus injection of Indocyanine
Green (ICG) detected by near-infrared spectroscopy in adult human heads, simulations were performed
using a two-layered model representing the extracerebral and intracerebral layers. Modeled optical data
were converted into tissue ICG concentration using either the one-detector modified Beer–Lambert law
(MBLL) method, or the two-detector partial path-length (PPL) method. The CBFs were estimated using
deconvolution and blood flow index techniques. Using the MBLL method, the CBFs were significantly
underestimated but the PPL method improved their accuracy and robustness, especially when used as
relative measures. The dispersion of the arterial input function also affected the CBF estimates. © 2007
Optical Society of America
OCIS codes: 170.3660, 170.3890, 170.6510.
1. Introduction
The measurement of cerebral blood flow (CBF) is a
crucial tool in assessing cerebral well being especially
in pathological patients. Regional CBF can be mea-
sured with imaging techniques such as dynamic
susceptibility contrast magnetic resonance imaging
(MRI), xenon computed tomography (CT), and positron
emission tomography (PET). These techniques provide
amap of CBF for the whole brain but are of limited use
to critically ill patients in the intensive care unit who
cannot be easily transferred to such scanners. High
operating costs also restrict their availability, and for
the latter two methods radiation exposure limits the
number of studies that can bemade. For these reasons,
measuring CBF optically at the bedside using near-
infrared spectroscopy (NIRS) is an attractive alterna-
tive. The NIRS technique involves placing one or more
optical sources and detectors on the surface of the head
overlying the cerebral region of interest. Although pro-
ducing only a single point measurement instead of a
2D cross-sectional map as provided by other imaging
modalities, this technique in principle provides a rel-
atively fast, simple, and inexpensive way to measure
localized CBF.
While the NIRS measurement of a relative CBF
(arbitrary units) can be performed using diffusion
correlation spectroscopy,1 an absolute CBF (units of
ml100 gmin) has to be measured using tracer
tracking techniques. Two main tracers have been
used in NIRS, namely, oxy-hemoglobin2 and Indocya-
nine Green (ICG).3,4 The use of oxy-hemoglobin as a
tracer involves first slightly lowering the subject’s
inspired oxygen fraction, and then sharply increasing
it to produce a bolus of oxy-hemoglobin flowing into
the brain, which acts as the tracer. For the first few
seconds, the venous outflow of the tracer can be as-
sumed to be zero and the CBF can be calculated from
the measurement of changes in arterial oxygen sat-
uration and tissue oxy-hemoglobin concentrations us-
ing the Fick principle. The need to reduce oxygen
intake can make this technique unsuitable for pa-
tients with brain injury, in whom CBF is most likely
to be measured. Also since only a few seconds worth
of data are used for the CBF calculation, the tech-
nique has a large coefficient of variation.2,5
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Another tracer often used is ICG, which is a con-
trast agent with high absorption in the near-
infrared range, and this produces a signal with a
greater signal-to-noise ratio than oxy-hemoglobin.
To perform a CBF measurement, a bolus of ICG is
injected intravenously, and the arterial ICG con-
centration may be recorded by a noninvasive pulse-
dye densitometer with the probe attached to a
peripheral site (e.g., the ear lobe, finger, or nose), or
by an invasive intra-arterial probe. The tissue ICG
concentration is measured by a near-infrared spec-
trometer with the probe placed on the head overly-
ing the region of interest. There are four main
approaches to the calculation of CBF from the re-
corded arterial and tissue ICG concentrations. The
first approach makes use of only the first few sec-
onds of data when the venous outflow of ICG can be
assumed to be zero4 and is similar to the method
used when oxy-hemoglobin is used as the tracer.
The CBF can then be calculated by applying the
Fick principle. This approach suffers from the same
robustness problem as the oxy-hemoglobin tracer
technique because of the relatively small amount of
data considered in the calculation.
The second approach considers the slope of the ini-
tial rise of the tissue ICG concentration curve, termed
the blood flow index (BFI),6–9 as an index of CBF.
However, BFIs are only comparable when the optical
properties of the measurement sites, the geometry,
and the circulating blood volume are the same. This
is true only during repeated measurements within
the same subject. This means that BFIs can be used
only as a trend measure to compare CBF at different
times in the same subject with a stable cerebral blood
volume (CBV) but not as an absolute measure of
CBF among different subjects. Another limitation is
that for a valid comparison of different BFI measure-
ments, their arterial input functions (AIFs) have to
be exactly the same, which can be difficult to achieve
in practice. Zierler10 discussed the changes in tissue
concentration of a tracer as a function of time and
pointed out that the tissue time-concentration curve
reflects not only the vascular physiology of the tissue
but also the AIF. The BFI is calculated from the initial
upslope of the tissue time-concentration curve and
does not consider the AIF (the arterial ICG bolus) at
all. Using BFIs with different AIFs to compare CBF
will therefore introduce significant errors.
The third approach exploits the concept of the im-
pulse residue function (IRF), which carries informa-
tion about the mean transit time (MTT), CBF, and
volume. The IRF is the tracer concentration depos-
ited in tissue when a unit bolus of tracer is injected
instantaneously in the arterial site, resembling a
delta function.11 To recover the IRF, the arterial and
tissue ICG concentrations are measured and used for
deconvolution. Brown et al.12 performed deconvolu-
tion with the constraints that the deconvolved IRF
was nonnegative and has a flat plateau followed by a
decreasing function. The study compared the CBF
estimated by using NIRS ICG measurements and
using CT measurements in six newborn piglets.
Paired t-tests showed no significant difference.
The fourth approach was reported by Keller et al.13
who derived the venous outflow as the convolution of
the arterial inflow and the transport function mod-
eled as a logarithmic normal density function. Using
the Fick principle, it was claimed that both the arte-
rial inflow and the venous outflow could be estimated
from the measured tissue ICG concentration, and ac-
cordingly the MTT could also be found. The CBV was
calculated as the division of the tissue ICG concen-
tration by the arterial ICG concentration. Finally, the
CBF was derived by dividing the CBV by the MTT.
This study also compared the absolute CBFs mea-
sured by NIRS and perfusion-weighted MRI in six
subjects and found some agreement (the differences
against their mean are within two standard devia-
tions).
The NIRS technique may seem attractive, but it
poses several challenges when applied to the adult
human head. First, its noninvasive nature means
that a measurement is taken from the surface of the
head and the measurement is subsequently contam-
inated by an unknown amount of extracerebral blood
flow. Second, the AIF is normally measured at a pe-
ripheral site and is assumed tomimic the AIF feeding
the arteries entering the field of view where the CBF
is measured, i.e., the carotid or middle cerebral ar-
teries. As a result, any dispersion of the AIF between
the two sites will affect the CBF estimate. These
issues have particular implications for CBFmeasure-
ments in adults with a thick scalp and skull and a
more substantial external vasculature.
A study using ICG and NIRS found a mean CBF of
8.3 ml100 gmin in 12 healthy adult volunteers us-
ing the IRF (deconvolution) method.7 This value is
very low compared to the CBF value of approximately
60 ml100 gmin as reported by other measurement
techniques such as MRI bolus tracking and xenon
CT. Indeed, some studies have concluded that mea-
suring CBF with NIRS techniques is unreliable.5,14
Most of the published papers on measuring CBF
with NIRS and ICG are experimental studies based
on one of the techniques described earlier. To address
the two issues raised above, it is necessary to conduct
experiments under strictly controlled conditions with
known variables, and this is difficult to carry out in
practice. We have therefore used physiologically and
experimentally informed computer simulations, which
are based on an analytical model of light transport in
a two-layered medium proposed by Kienle et al.15
Both optical attenuation and mean time delay (ex-
pressed as a phase delay for a modulated source sig-
nal) were calculated.
2. Methods
A. Physiological Model
1. Indicator-Dilution Theory
The indicator-dilution theory considers a tracer being
injected into the blood stream and mathematically
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relates the blood flow F, the AIF Cartt and the tissue
time-concentration curve, Ctist using the concept of
the IRF, Rt16:
CtistF 
0
t
CartRtd, (1)
where t is time and  is an integration variable. The
IRF corresponds to the amount of tracer deposited in
the tissue, i.e., Ctist when the AIF is a Dirac delta
function (its integral is equal to 1 at the time of input
and to zero at all other times). The first moment of
Rt is the MTT and the blood volume (V) is VMTT
 F according to the central volume principle.16
Within the context of this study, the AIF corresponds
to ICGtart, and the tissue time-concentration curves
correspond to ICGtext and ICGtint for the ex-
tracerebral layer and the intracerebral layer, re-
spectively. Based on this formulation, we can
incorporate known values of blood flow and MTT
together with a modeled ICGtart, which we simu-
lated based on experimental data, to generate
ICGtext and ICGtint.
2. Physiological Parameters
Table 1 lists the values of blood flow, blood volume,
and MTT used in the simulations. Other parameters
in the table will be further discussed in Subsection
2.B.2. Using the xenon CT technique, the blood flow
in the extracerebral layer was reported to be 5–8
ml100 gmin.17 A mean value of 6.5 ml100 gmin
has been used here. In another study, the mean ab-
solute oxy- and deoxy-hemoglobin concentration in
the forehead were found to be 6.4 and 4.3 M, respec-
tively using near-infrared spatially resolved spec-
troscopy with an optical probe having one source and
nine detectors (SD spacings ranging from 1.75 to
16.79 mm).18 The total absolute tissue hemoglobin
concentration (i.e., 10.7 M) was converted to the
blood volume of 0.7 ml100 g for the extracerebral
layer in Table 1. The conversion involves the use of a
nominal blood hemoglobin concentration of 14 gdl
and a small-to-large-vessel hematocrit ratio of 0.69.19
The values for the blood flow and volume in the brain
were obtained from a MRI CBF simulation study by
Calamante et al.20 who found them suitable for sim-
ulating the blood flow and volume in the gray matter.
3. Simulation of the Arterial Input Function
The experimental ICGtart wasmeasured by a pulse
dye-densitometer (DDG-2001 Nihon Kohden, Tokyo,
Japan) with a nasal probe on a healthy adult volun-
teer. We found by visual inspection that the lognor-
mal function, which has been used to approximate
the arterial input function in the estimation of car-
diac output,21 also sufficiently fits the first pass of our
experimentally measured ICGtart. One empirical
feature we found in the time-concentration curve of
the NIRS measured signal is that the recirculation is
more dominant than that measured by other tech-
niques such as MRI and CT. We therefore also con-
sider the recirculation and ICGtart is modeled as
the summation of three lognormal functions:
ICGtart 
n1
3
An expknft, tn2,
ft, tn
lntntn for tn
0 otherwise, (2)
where A1  11.5, k1  2.6, t1  4.2 s, 1  0 s, A2 
1.1, k2  0.25, t2  25 s, 2  15 s, A3  0.8, k3  4,
t3  25 s, and 3  1 s. The modeled and experimen-
tally measured ICGtart are plotted in Fig. 1(a) for
comparison. Another widely used model for the arte-
rial input function is the gamma variate function.20,22
4. Simulation of the Impulse Residue Functions
A simple and widely used model for the IRF in tissue
is the exponential function, which considers the vas-
culature bed as one single and well-mixed compart-
ment. It has been used to model the IRF in the
brain20,22: Rt  exptMTT where t  0 and the
first moment of R(t) is MTT. From the measurement
Fig. 1. (a) Modeled and experimentally measured arterial input
function ICGtart. (b) Modeled tissue ICG concentration time
curves in the extracerebral layer ICGtext and intracerebral layer
ICGtint.
Table 1. Physiological and Optical Parameters (Baseline Value)a
Extracerebral
Intracerebral
(Gray Matter)
Blood volume (ml100 g) 0.7 4
Total Hb concentration,
[HbT] (M)
11 61
Blood flow (ml100 gmin) 6.5 60
Mean transit time (s) 6.5 4.0
Water content (%) 70 71
Background absorption
coefficient, a
bk (mm1)
0.015 0.023
Dispersion,  (s) 6 0
aThe superscript  denotes the parameter whose value is to be
changed in the numerical experiments.
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site to the site where ICG enters the arteries feeding
the tissue in the field of view, ICGtart may be dis-
persed. The dispersion can be modeled by convolving
R(t) with a dispersion function expt and the
effective IRF becomes20
Rt
MTT
MTT
expt exptMTT, (3)
where t  0 and  is the dispersion factor in units of
seconds.
5. Simulation of the Tissue Indocyanine Green
Concentration Curves
Using the AIF model, the IRFs, and the MTT and the
blood flow values shown in Table 1, ICGtext and
ICGtint can be simulated as shown in Fig. 1(b). It
can be seen that ICGtext is more dispersed and has
a lower peak value, which agrees with the general
behavior of the tissue tracer time-concentration curve
in the extracerebral layer found in a MRI study.23
B. Optical Model
1. Two-Layered Analytical Model
To simulate the light propagation in the extracere-
bral layer and the intracerebral layer, a two-layered
model for frequency domain measurements proposed
by Kienle et al.15 has been adopted. Given the depth
of the first layer, the modulation frequency  fmod, the
absorption coefficients a and the reduced scatter-
ing coefficients s in the upper and lower layers, this
model can predict the reflectance (r) at a predefined
SD spacing and the phase angle () between the
source and the detector. The model assumes a flat
geometry both at the surface and at the boundary
between the upper and the lower layers, and the
lower layer is infinitely thick. It also assumes a
tissue–air refractive index mismatch.
2. Optical Parameters
Using the two-layered model, we can predict both the
reflectance and the phase angles at different surface
measurement points with assigned a and s in the
two layers. Here the two optical coefficients are ex-
pressed as a and s to highlight their wave-
length dependency. Two equations have been used to
form a in each layer. The first equation calculates
the a before the ICG enters the field of view and
is denoted by a
0 here:
a
0HHbHbT1SO2	HbO2HbTSO2
	a,H2OW	a
bk, (4)
where HHb and HbO2 are the specific absorption
coefficients of deoxy- and oxy-hemoglobin M1mm1,
[HbT] is the total hemoglobin concentration M,
SO2 is the tissue oxygenation (as a fraction),W is the
water content (as a fraction), and a,H2O is the ab-
sorption coefficient of 100% water mm1, and abk is
a wavelength independent background absorption
mm1. It is assumed that the physiology does not
change over time, and subsequently these parame-
ters are assumed to be time invariant. The values of
[HbT] andW for each layer are listed in Table 1. The
water content of each layer has been measured pre-
viously using the MRI technique.24 The SO2 for the
two layers has been set to a nominal value of 0.7. The
a in the two layers calculated using these param-
eters was smaller than that used by Okada and
Delpy.25 A wavelength-independent background a
bk
was therefore added so that the total value matched
those in Okada and Delpy25 at 800 nm, i.e., the a
bk for
the extracerebral layer  0.015 mm1 and the a
bk for
the intracerebral layer  0.023 mm1. The existence
of the background absorption was discussed previ-
ously by Essenpreis et al.26 and Hueber et al.27 Using
these values, the total extracerebral a800 nm 
0.018 mm1, and the total intracerebral a800 nm 
0.036 mm1, which were the same values used in
Okada and Delpy.25 For comparison this approach
also resulted in extracerebral and intracerebral
a759 nm of 0.019 mm1 and 0.037 mm1, respec-
tively, which are comparable to the experimentally
found extracerebral and intracerebral a759 nm
of 0.015 and 0.030 mm1 found in a previous study.28
When ICG enters the field of view, a time-variant
absorption change is introduced and the correspond-
ing a, i.e., a
ICGt,  can be modeled as
a
ICGt, a0	 ICGtICG, (5)
where ICG is the specific absorption coefficient
of ICG. The [ICG(t)] here corresponds to either
ICGtext or ICGtint whose generation has been
discussed in Subsection 2.A. The values of HHb,
HbO2, ICG, and a,H2O used here were obtained
from previous measurements performed in our labo-
ratory.4,29 It should be noted that all the absorption
coefficients here are based on the logarithm base of e,
rather than 10, in order to be consistent with the
diffusion theory.
For the s in the extracerebral layer, we em-
ployed an expression derived by Doornbos et al.18 who
conducted spatially resolved spectroscopy measure-
ment on the human forehead: s
ext  a 
 103b

 103 where a  1141, b  0.84, and 	 is in nano-
meters. In this study, the maximum SD spacing is
16.79 mm, and the results are applicable mainly to
the extracerebral layer.
van der Zee et al.30 measured s for brain tissues
in vitro at 800 nm. Matcher et al.31 measured s in
the adult human forehead in vivo using time-resolved
spectroscopy with a SD spacing of 40 mm, which was
believed to probe both the extracerebral layer and the
intracerebral layer. Here we used s800 nm  2.2
mm1 for the graymatter found by van der Zee et al.30
as the reference value and adopted the wavelength
dependency found by Matcher et al.31 to calculate
s at other wavelengths. The formulation of s
in the intracerebral layer is written as: s
int 
2.2a 	 b800a 	 b where a  6.5 
 104,
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b  1.45, and 	 is in nanometers. For   800 nm,
s
int  2.2 mm1.
Using the techniques discussed in this subsection,
the reflectance and phase angles were predicted at
775, 813, and 853 nm, which were three of the wave-
lengths used in the spectrometer during a previous
in vivo study.7 The attenuations were calculated from
reflectance, i.e.,Aloger, and the total mean path
length calculated from the phase angles, i.e., L 
2fmodctis, where ctis is the speed of light in tissue.
The optical data were predicted at two measurement
points with SD spacings of 45 and 50 mm,which were
chosen to be the same as the configuration of the
optodes used in a previous study.7
Before ICG entered the field of view, the path
length at a SD spacing of 50 mm is 310 mm at
813 nm, which corresponds approximately to a differ-
ential path-length factor (DPF) of 6.2. This value
agrees reasonably well with the experimental finding
of 6.1 at 807 nm, using the age-dependent equation of
DPF  4.99  0.067A0.814 where A (age)  30 years,32
and adds to our confidence that the two-layered an-
alytical model and the optical and physiological pa-
rameters used (as shown in Table 1) are suitable.
C. Conversion of Optical Data to Concentrations
1. Modified Beer-Lambert Law Method
One widely used technique to convert attenuation
into ICG concentration is by using the MBLL4,7,12:
C  1AL where L is the optical mean path
length, C is a column vector containing the changes
in concentrations of ICG, deoxy- (HHb) and oxy-
hemoglobin HbO2, i.e., CICG CHHb CHbO2
T, 1 is
the inverse of a matrix containing the specific absorp-
tion coefficients of ICG, HHb, and HbO2 at different
wavelengths, and A is a column vector containing
changes in attenuation at different wavelengths. In
this work, A  AICG1  A01, AICG2  A02,
AICG3 A03T A1, A2, A3T where
A0, and AICG are attenuations before and after
ICG enters the field of view, and the three wave-
lengths used are 775, 813, and 853 nm. Since the
concentrations of HHb and HbO2 are set to be con-
stant before and after the appearance of ICG, it is
expected that the resulting CHHb and CHbO2 are
close to zero. It should be noted that L is in fact
wavelength dependent but a fixed value is often used
and scaling factors correcting for the wavelength de-
pendency are incorporated in . This formulation as-
sumes a homogeneous medium.We refer to the use of
a single-detector measurement and the MBLL as the
MBLL method.
2. Partial Path-Length Method
Hiraoka et al.33 introduced the concept of partial path
lengths to extend the MBLL to heterogeneous media.
The partial path length of a layer is defined as a
partial derivative of the measured A versus the a at
that layer and can be considered as the mean path
length that light has traveled in that layer. For a
two-layered model with two detectors, we have
A1A2	 1,1 1,22,1 2,2	a,1a,2	, (6)
where A1 and A2 are the changes of attenu-
ation [i.e., AICG  A0] measured by detectors 1
and 2, a,1 and a,2 are the changes in the
absorption coefficient in layers 1 (upper) and 2
(lower), m,n is the partial path length at layer n as
measured by detector m (m, n  1 or 2). Subse-
quently, a in both layers can be estimated by
MR1A, where M a,1, a,2T andR
is the matrix containing all the partial path lengths
m,n in Eq. (6). The partial path lengths, however,
cannot be measured directly but can be estimated
iteratively with Monte Carlo simulations or a solu-
tion of the diffusion equation using frequency or time
domain measurements.28 In this work they are esti-
mated by 1,1  A1a,1, where a,1 is
set to a small value, e.g., 0.001, and A1 is the
corresponding change of attenuation predicted by the
optical model, and subsequently, 1,2  L1
 1,1. The corresponding physiological and optical
parameters are the baseline values as shown in Table
1. Both 2,1 and 2,2 can be found similarly. Once
the a in the brain, i.e., a,2, becomes avail-
able, the corresponding concentrations can be calcu-
lated byC 1a,2. Here we refer to the use of two
detector measurements and the partial path-length
formulation as the PPL method. As an example, us-
ing the modeling techniques described here and the
parameters in Table 1, the partial path length in the
brain and the mean path length were estimated to be
18.8 and 254.5 mm for   775 nm, SD spacing 
45 mm and the thickness of the first layer  8 mm.
The ratio of partial to mean path length is 0.069. For
comparison a previous study28 in which a time-
resolved spectrometer and Monte Carlo simulations
were used found the partial path length in the brain
and the mean path length of an adult subject to be
26.4 and 206.6 mm for   759 nm, SD spacing 
30 mm and the thickness of the scalp and skull 
7.9 mm. The corresponding ratio of partial to mean
path length is 0.128. The discrepancies between these
results can be attributed to different assumptions
and optical properties used.
Using either theMBLLmethod or the PPLmethod,
the tissue ICG concentration can be calculated. When
the MBLL method is used, the notation ICGtdet2 is
used to denote the tissue ICG concentration as mea-
sured by detector 2 (SD spacing 50 mm). When the
PPLmethod is used, the notation ICGtdet1&2 is used
to indicate that both detectors 1 (SD spacing 
45 mm) and 2 are used. Figure 2 depicts ICGtdet2
and ICGtdet1&2 predicted with three different dis-
persion factors in the intracerebral layer (i.e.,   0,
0.5, and 1 s) and an extracerebral thickness of
10 mm. It should be noted that ICGtdet2 accounts
for a weighted average of the tissue ICG concentra-
tions in the extracerebral layer, i.e., ICGtext and
the intracerebral layer, ICGtint because of the as-
sumption of a homogeneous medium. On the other
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hand, ICGtdet1&2 corresponds to ICGtint only be-
cause of the two-layer assumption. It will be shown in
Section 3 that the PPL method will provide CBF
estimates less sensitive to the extracerebral blood
flow. It can be seen from Fig. 2(a) that ICGtdet2 is
more dispersed and has a lower peak value, bearing
more similarities to ICGtext than ICGtint [see
Fig. 1(a)]. This indicates the influence of the extra-
cerebal blood flow on ICGtdet2. On the other hand,
ICGtdet1&2 in Fig. 2(b) is more similar qualitatively
to ICGtint showing a high sensitivity to intracere-
bral changes.
D. Estimation of Cerebral Blood Flow
1. Deconvolution
Rewriting Eq. (1) in discrete form for the tracer ICG:
ICGtjtist ·F ·
i0
j
ICGtjart ·Rtj ti, (7)
where ICGttis is the tissue ICG concentration mea-
sured by either theMBLLmethod or the PPLmethod
as discussed in the previous subsection, and t is the
sampling interval. Deconvolution is basically a nu-
merical process to recover F · R(t) from the measure-
ments ICGtart and ICGttis. The singular value
decomposition (SVD) approach has been used to per-
form deconvolution in general34 and in CBFmeasure-
ments with MRI bolus tracking.35 The SVD has a
threshold that allows it to handle noisy data (a high-
er threshold for a higher level of noise) and main-
tain a stable solution. Since Rt has a maximum
value of 1, the maximum value of x  F · Rt0,
F · Rt1, . . . , F · RtN1T is F, i.e., CBF. In actual
measurements, there is a time delay between
ICGtart measured at a peripheral site and
ICGttis measured over the head, potentially lead-
ing to erroneous results after deconvolution. How-
ever, the time delay can be compensated for by
manually synchronizing the rise of the two curves.
2. Blood Flow Index
As an alternative to deconvolution, relative CBF can
be quantified using the BFI,6 which is defined here as
the gradient of ICGttis during the initial inflow of
ICG, i.e., the difference between 90% and 10% of the
peak value over the corresponding time interval.7
E. Numerical Experiments
Three numerical experiments were performed to in-
vestigate different aspects of the CBF and BFI esti-
mations:
Numerical Experiment 1: The extracerebral blood
flow was fixed at 6.5 ml100 gmin, while the CBF
varied between 20% and 	20% (in steps of 10%)
around the baseline value of 60 ml100 gmin.
Numerical Experiment 2: The extracerebral blood
flow varied between 20% and 	20% (in steps of
10%) around the baseline value of 6.5 ml100 gmin,
while the CBF was fixed at 60 ml100 gmin.
Numerical Experiment 3: Both the extracerebral
blood flow and CBF were fixed at 6.5 and 60
ml100 gmin, while the dispersion factor in the vas-
culature varied between 0 and 1 s (in steps of 0.25 s).
The dispersion factor in the vasculature was set
to zero for Numerical Experiments 1 and 2. Table 2
summarizes the values of all the parameters used
in the three experiments. The values of other pa-
rameters such as the water content, background
absorption, and reduced scattering coefficients were
the same as those shown in Table 1. Kohl-Bareis
et al.23 found that the MRI perfusion signals using
gadolinium-DTPA as a tracer were more dispersed
in shape at the extracerebral site than those at the
intracerebral site. To incorporate this finding, a
larger dispersion factor of 6 s was used for R(t) in the
extracerebral layer. Also, R(t) was normalized to give
a maximum value of 1 so that the maximum value of
the deconvolved F · R(t) corresponds to the extrace-
rebral blood flow. In each numerical experiment, the
optical data (attenuation and phase angle) were pre-
dicted from the two-layered analytical model while
the thickness of the upper layer varied between 8 and
12 mm in steps of 2 mm.
Table 2. Parameters Used in the Three Numerical Experiments
Numerical
Experiment
Extracerebral
Blood Flow
(ml100 gmin)
Cerebral
Blood Flow
(ml100 gmin)
Dispersion Factor
in the
Intracerebral
Layer  (s)
1 6.5 48, 54, 60,
66, 72
0
2 5.2, 5.85, 6.5,
7.15, 7.8
60 0
3 6.5 60 0, 0.25, 0.5,
0.75, 1
Fig. 2. (a) Tissue ICG time-concentration curves calculated by the
MBLL method using detector 2 (SD spacing  50 mm), ICGtdet2
with three different dispersion factors,   0, 0.5, and 1 s. (b) Tissue
ICG time-concentration curves calculated by the PPL method using
detectors 1 and 2 (SD spacings 45 and 50 mm), ICGtdet1&2 with
three different dispersion factors,   0, 0.5, and 1 s.
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In each numerical experiment, the predicted opti-
cal data were analyzed by the MBLL method and the
PPL method. When using the MBLL, the mean path
length needs to be calculated from the phase angle.
Strictly speaking, themean path lengthLt,  is both
time and wavelength dependent. In reality, the ex-
perimentally measured phase angles are often very
noisy, which in turn affects the accuracy of the esti-
mated Lt, . Therefore one average phase angle is
often used for a period of time. In this work we also
used one phase angle (the point before the ICG ap-
pears) at each wavelength generated by the two-
layered analytical model to calculate one L for the
entire tissue ICG time-concentration curve. To use
the PPL method, the partial path lengths in the up-
per and lower layers as measured by the two detec-
tors, i.e., m,n m, n  1 or 2 were estimated using a
first-order approximation as described in Subsection
2.C.2. The partial path lengths are also time and
wavelength dependent, i.e., m,nt, , but to estimate
them accurately using experimental measurements
we need to know the evolution of at,  in the two
layers, which is in fact what we are trying to mea-
sure. Therefore it was assumed that the partial path
lengths did not change significantly during the inflow
and clearance of the ICG, and they were estimated
before the ICG appeared in the field of view. This
assumption inevitably introduced certain errors,
which we will further discuss later. For both meth-
ods, the threshold in the deconvolution was set to a
rather small value of 1% of the maximum singular
value because no noise was present in the predicted
data.
3. Results
Here we report the results obtained from the three
numerical experiments. For each experiment, the
estimated CBFs are given in both absolute units
ml100 gmin and relative units (% change). The
estimated absolute CBFs are biased to different de-
grees owing to the presence of the extracerebral blood
flow in all cases. However, the estimated relative
percentage changes in CBFs are in some cases quite
accurate. For Numerical Experiments 1 and 2 (Figs.
3 and 4), all the relative percentage changes were
calculated with respect to themiddle value (out of five
values), while in Numerical Experiment 3 (Fig. 5)
the results corresponding to the dispersion factor  
0 s (the first value) were used as the reference values.
The absolute BFI values in terms of Ms depend
on the optical properties of the measurement site and
the total circulating blood volume, which are likely to
differ in different subjects. Therefore absolute BFIs
cannot be compared between different subjects. Us-
ing BFI in the same subject at different times, rela-
tive percentage changes in BFIs are sufficient.
Therefore we present only the results of relative per-
centage changes in BFIs here but not the absolute
values.
Figures 3, 4, and 5 show the results of the three
numerical experiments. In all the figures, the three
panels on the left are the results obtained using the
MBLL method (single detector with 50 mm SD spac-
ing) while the three on the right are the results ob-
tained using the PPL method (two detectors with
Fig. 3. Numerical Experiment 1: Extracerebral blood flow (the up-
per layer) was kept constant at 6.5 ml100 gmin, and the real CBF
(the lower layer) varied between20% and 20% of its baseline value
at 60 ml100 gmin. (a), (c), and (e) Results obtained using the
MBLL method; (b), (d), and (f) results obtained using the PPL
method. The results are presented as absolute values (ml100
gmin) for estimated CBFs in (a) and (b), and as relative values (%
change from the middle value) for estimated CBFs and BFIs in (c),
(d), (e), and (f). Different thicknesses of the extracerebral layer at 8
(), 10 	 and 12 (Œ) mmwere used. The dotted line represents the
ideal estimation of CBF, which follows exactly the real CBF.
Fig. 4. Numerical Experiment 2: CBF (the lower layer) was kept
constant at 60 ml100 gmin, and the extracerebral blood flow (the
upper layer) varied between 20% and 20% of its nominal value at
6.5 ml100 gmin. (a), (c), and (e) Results obtained using the MBLL
method. (b), (d), and (f) Results obtained using the PPLmethod. The
results are presented as absolute values (ml100 gmin) for esti-
mated CBFs in (a) and (b) and as relative values (% change from the
middle value) for estimated CBFs and BFIs in (c), (d), (e), and (f).
Different thicknesses of the extracerebral layer at 8 (), 10 	 and
12 (Œ) mm were used. The dotted line represents the ideal estima-
tion of CBF, which is not biased by the extracerebral blood flow.
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spacings of 45 and 50 mm, respectively). An identity
line (dotted line) was drawn, where appropriate, on
each figure corresponding to the ideal CBF or BFI
estimates.
A. Influence of the Extracerebral Blood Flow on Cerebral
Blood Flow and Blood Flow Index Estimation
In the first two numerical experiments, we investi-
gated the influence of the extracerebral blood flow on
the CBF and BFI estimations. Figure 3 shows the
results of Experiment 1 whereby the extracerebral
blood flow was kept constant at 6.5 ml100 gmin,
and the real CBF varied between 20% and 20% of
its baseline value of 60 ml100 gmin. Using the
MBLL, it can be seen from Fig. 3(a) that all the
estimated absolute CBF was between 6.5 and
8.5 ml100 gmin, which are close to the constant
extracerebral blood flow at 6.5 ml100 gmin show-
ing its influence on the CBF estimates. The relative
percentage changes in the estimated CBF and BFIs
as shown in Figs. 3(c) and 3(e) do show some small
changes as the underlying real CBF varies [e.g., for
extracerebral thickness at 8 mm, Fig. 3(c) shows that
the percentage change of estimated CBF is only5%
for real CBF changes 20%]. However, the sensitiv-
ities are therefore small. This means that the per-
centage changes of both CBF and BFI are largely
underestimated. The sensitivity of those results cor-
responding to a thinner extracerebral layer (e.g.,
8 mm) is marginally higher. These results once again
show that both the CBF estimates and the BFIs are
dominated by the extracerebral blood flow, which was
kept constant in this experiment.
Using the PPL method, the estimated absolute
CBF is comparatively closer to the identity line as
shown in Fig. 3(b). As discussed in Subsection 2.E,
only the partial path lengths before the appearance of
ICG were estimated and used for the whole tissue
ICG time-concentration curve. Although this ap-
proach makes this method more readily applicable in
practice, the errors introduced resulted in the dis-
crepancies between the absolute CBF estimates and
the identity line. It is also the case that the thick-
nesses of the extracerebral layer have an effect on
these absolute CBF estimates, and in this example
the absolute CBF estimates approach the identity
line as the extracerebral layer thickness becomes
larger, e.g., 12 mm. Figure 3(d) shows the relative
percentage changes of CBFs, and in all cases the
estimates follow the identity line. Although not as
good as its CBF counterpart, the percentage changes
in BFIs still follow the identity line reasonably closely
as shown in Fig. 3(f). It is also noted that similar
relative percentage changes are observed when dif-
ferent extracerebral layer thicknesses are used.
In Numerical Experiment 2, the CBF was kept
constant at 60 ml100 gmin while the extracerebral
blood flow was varied between20% and	20% of its
baseline value of 6.5 ml100 gmin. Using theMBLL
method, Fig. 4(a) shows that the estimated absolute
CBF varies linearly between 5 and 9ml100 gmin in
all cases, which again indicates the large influence of
the extracerebral blood flow. Figure 4(c) further con-
firms the dominance of the varying extracerebral
blood flow on the estimates and shows that the
relative percentage changes of the CBF estimates
closely follow the changes in the extracerebral blood
flow. Figure 4(e) shows that the percentage changes
in BFIs are equally affected by the varying extrace-
rebral blood flow although in a nonlinear fashion.
Figure 4(b) shows the absolute CBF estimates us-
ing the PPLmethod. It can be seen that the estimates
are in general insensitive to changes in the extrace-
rebral blood flow. The discrepancies between the real
CBF at 60 ml100 gmin and the estimated values
depend on the thickness of the extracerebral layer. In
this example, the discrepancy is smallest when the
thickness is 12 mm. The insensitivities of the CBF
estimates and the BFI to varying extracerebral blood
flow are further illustrated in Figs. 4(d) and 4(f)
where the relative percentage changes are almost
zero in all cases. It is also noted that similar relative
percentage changes are observed when different ex-
tracerebral layer thicknesses are used.
B. Influence of the Vasculature Dispersion on Cerebral
Blood Flow and Blood Flow Index Estimation
In Numerical Experiment 3, both the extracerebral
blood flow and the CBF were kept constant at 6.5 and
60 ml100 gmin, respectively, while the dispersion
factor for the intracerebral layer varied between 0
and 1 s (in steps of 0.25 s). Figures 5(a), 5(c), and 5(e)
Fig. 5. Numerical Experiment 3: Both the CBF (the lower layer)
and the extracerebral blood flows (the upper layer) were kept
constant at 60 and 6.5 ml100 gmin, respectively. The  disper-
sion factor in the intracerebral layer varied between 0 and 1 s (in
steps of 0.25 s). (a), (c), and (e) Results obtained using the MBLL
method. (b), (d), and (f) Results obtained using the PPL method.
The results are presented as absolute values (ml100 gmin) for
estimated CBFs in (a) and (b) and as relative values (% change
from the first value when   0 s) for estimated CBFs and BFIs in
(c), (d), (e), and (f). The results were calculated with thicknesses of
the extracerebral layer at 8 (), 10 	 and 12 (Œ) mm. The dotted
line represents the ideal estimation of CBF, which is not biased by
any dispersion in the vasculature.
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show the results obtained using the MBLL method.
As discussed in Subsection 3.B, the ICGttis ob-
tained using this method is dominated by the extra-
cerebral blood flow, and this is confirmed by Fig. 5(a)
in which the absolute CBF estimates are much
smaller than the real CBF. Ideally, one would hope
that the CBF estimates and the BFIs would remain
constant and not be altered by the dispersion, i.e.,
zero relative percentage changes. The relative per-
centage changes of CBF estimates and BFIs shown in
Figs. 5(c) and 5(e) increase by approximately 5% and
10%, respectively (for extracerebral thickness of 8
mm), as the dispersion factor increases from 0 to 1 s.
These erroneous changes are in fact smaller than
those obtained by the PPLmethod as shown in Figs.
5(d) and 5(f). However, it does not mean that the
MBLL method is more robust in the presence of
dispersion but that ICGttis calculated using the
MBLL method is less sensitive to intracerebral
changes. This can be better explained by referring to
Fig. 2(a) in which ICGtdet2 (ICGttis measured by
detector 2) corresponding to three dispersion factors
in the intracerebral layer are plotted. It can be seen
that their shapes are similar to each other, indicating
that any changes in the intracerebral layer has small
influence on ICGtdet2.
Using the PPL method, the absolute CBF esti-
mates are reduced by a considerable amount as the
dispersion factor increases from 0 to 1 s as shown in
Fig. 5(b). Figure 5(d) shows the relative percentage
changes, which are as much as 40% when the dis-
persion factor is 1 s. The strong effect of dispersion on
the CBF estimates can be better appreciated by re-
ferring to Fig. 2(b), which shows that ICGtdet1&2
becomes more dispersed and has a lower peak value
as the dispersion factor is increased from 0 to 1.
These characteristics of the curves translate to a
large reduction of the CBF estimates after decon-
volution. As for the BFI in Fig. 5(f), the relative
percentage changes are reduced by approximately
25% when the dispersion factor increases from 0
to 1 s. Since, the BFI is calculated from the initial
rise of ICGtdet1&2 and is not influenced by the
dispersion of the remaining part of the curve, it
turns out that the reduction in the percentage
change in BFI is smaller than those in the CBF
estimates.
4. Discussions and Conclusions
The use of NIRS and ICG in assessing cerebral he-
modynamic variables has been attempted by many
research groups. It has been reported that the qual-
itative shape of the measured tissue ICG concentra-
tion time curves can reflect the health of cerebral
perfusion.36,37 However, turning the tissue ICG
time-concentration curves into quantitative CBF es-
timates in ml100 gmin or BFIs is more difficult and
controversial. We have shown through computer sim-
ulations that CBF (absolute and relative) and BFIs
(relative) estimated using the MBLL method (one
detector) are heavily weighted toward the extracere-
bral blood flow.
The PPL method (two detectors) improves the sen-
sitivities of the CBF estimates (absolute and relative)
and the BFIs (relative) to the underlying real CBF
changes and reduces the influence of varying extrace-
rebral blood flows (increasing robustness). An accurate
quantification of absolute CBF in ml100 gmin using
this method, on the other hand, is difficult because
the PPL method involves the estimation of partial
path lengths using computer simulations and there-
fore requires accurate measurements of optical prop-
erties in each layer, which are difficult to obtain in
practice. As for BFI as a relative measure, it should
be noted that the initial rise of a tissue ICG concen-
tration time curve is not linear, and subsequently the
corresponding BFI does not increase linearly with the
underlying real CBF. This explains the lack of lin-
earity of BFIs we found in Figs. 3(e), 3(f), 4(e), 4(f),
5(e), and 5(f). Our results suggest that using the CBF
estimates obtained from the PPL method as relative
measures to quantify percentage changes from a
baseline value is by far the most reliable approach
to assess cerebral perfusion. Different extracerebral
thicknesses also do not seem to influence these per-
centage changes significantly as demonstrated in
Figs. 3(d) and 4(d).
The problem becomes more complicated when the
dispersion in the vasculature is taken into account.
Figure 5 shows that the CBF estimates and the BFIs
are biased in the presence of dispersion even using
the PPL method. This is in fact a more fundamental
problem of the dilution indicator methodology. The
IRF approach cannot distinguish tracer dispersion in
the feeding vessels, i.e., ICGtart from tracer reten-
tion in the capillary bed of the field of view, i.e.,
ICGtint.20,38 This limitation is particularly relevant
in NIRS measurements because ICGtart is often
measured at a peripheral site (e.g., nose or ear lobe),
which is some distance away from the actual feeding
vessels in the brain. It has been suggested that re-
solving this problem requires the modeling of the
vasculature, which has been attempted in the MRI
bolus tracking technique.38
Apart from the PPL approach, one other possible
method to estimate the optical properties in the two
layers separately is to use the two-layered optical
model for inversion.15 This has not been done here
because it is generally not valid to use the same
model for forward modeling and inversion. However,
in general the two-layered model can be used for
inversion in experimental measurements although
there may be issues concerning long computation
time and robustness.
We do not expect the two-layered optical model
used here to be able to accurately predict the actual
optical data measured in a real human head. The
two-layeredmodel is a gross simplification in that the
complicated layered structure of a head is simplified
to two flat layers corresponding to the extracerebral
and intracerebral layers. Also, the cerebrospinal fluid
has been ignored. Okada and Delpy25 showed that
the presence of low-scattering cerebrospinal fluid in-
creases the partial path length in the brain and hence
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the actual optical measurements on the surface of the
head may have a higher sensitivity to the real CBF
than our results shown. In any case, the relatively
effective method we found here, namely, the PPL
method, involves the weighted subtraction of a as
measured by two detectors. Any discrepancies attrib-
utable to the use of an inaccurate optical model apply
equally to both a and are substantially canceled out
in the subtraction. We therefore expect the results
obtained from the PPL method using the proposed
modeling technique to be sufficiently valid. In a re-
cent experimental study in which the CBFs of ten
adult volunteers were increased (as assessed by
transcranial Doppler) by the administration of acet-
azolamide, we found that the velocity of the middle
cerebral artery as measured by transcranial Doppler
was increased by 49  21%. However, the BFIs
calculated using the MBLL method were unable to
detect a statistically significant increase of the un-
derlying CBF.9 We are currently investigating the
use of the PPL method in this set of data.
When different baseline physiological or optical pa-
rameters (e.g., water content or a
bk) are used, the
absolute CBF and BFIs obtained will also differ be-
cause the general distribution of light would have
been changed as a result. We carried out a test (re-
sults not shown here) in which the extracerebral and
intracerebral a
bk were reduced to half of the values
shown in Table 1. Unsurprisingly, we found different
values for the absolute CBF and BFIs. However, the
central messages stated here still applied, i.e., (1)
using the MBLL method, the absolute CBF was sig-
nificantly underestimated, (2) the PPL method im-
proved the accuracy and robustness, (3) the CBF
estimates were best used as relative measures, and
(4) the dispersion of the AIF affected the CBF esti-
mates.
The authors thank Hamamatsu Photonics KK,
University College London and University College
Hospital Trustees, the Interdisciplinary Research
Collaboration of the Engineering and Physical Sci-
ences Research Council andMedical Research Council
(grant 075608) for their support of this work. We also
thank Alwin Kienle for his help with the implementa-
tion of the two-layer analytical model.
References
1. T. Durduran, G. Yu, M. G. Burnett, J. A. Detre, J. H. Green-
berg, J. Wang, C. Zhou, and A. G. Yodh, “Diffuse optical mea-
surement of blood flow, blood oxygenation, and metabolism in
a human brain during sensorimotor cortex activation,” Opt.
Lett. 29, 1766–1768 (2004).
2. C. E. Elwell, M. Cope, A. D. Edwards, J. S. Wyatt, D. T. Delpy,
and E. O. R. Reynolds, “Quantification of adult cerebral hemo-
dynamics by near-infrared spectroscopy,” J. Appl. Physiol. 77,
2753–2760 (1994).
3. J. Patel, K. Marks, I. Roberts, D. Azzopardi, and A. D.
Edwards, “Measurement of cerebral blood flow in newborn
infants using near-infrared spectroscopy with indocyanine
green,” Pediatr. Res. 43, 34–39 (1998).
4. R. Springett, Y. Sakata, and D. T. Delpy, “Precise measure-
ment of cerebral blood flow in newborn piglets from the bolus
passage of indocyanine green,” Phys. Med. Biol. 46, 2209–2225
(2001).
5. C. R. J. C. Newton, D. A. Wilson, E. Gunnoe, B. Wagner, M.
Cope, and R. J. Traystman, “Measurement of cerebral blood
flow in dogs with near-infrared spectroscopy in the reflectance
mode is invalid,” J. Cereb. Blood Flow Metab. 17, 695703
(1997).
6. W.M. Kuebler, A. Sckell, O. Habler,M. Kleen, G. E. H. Kuhnle,
M. Welte, K. Messmer, and A. E. Goetz, “Noninvasive mea-
surement of regional cerebral blood flow by near-infrared spec-
troscopy and indocyanine green,” J. Cereb. Blood Flow Metab.
18, 445–456 (1998).
7. F. Gora, S. Shinde, C. E. Elwell, J. C. Goldstone, M. Cope, D. T.
Delpy, and M. Smith, “Measurement of cerebral blood flow
in adults using near-infrared spectroscopy and indocyanine
green,” J. Neurosurg. Anesthesiol. 14, 218–222 (2002).
8. B. P. Wagner, S. Gertsch, R. A. Ammann, and J. Pfenninger,
“Reproducibility of the blood flow index as noninvasive, bed-
side estimation of cerebral blood flow,” Intensive CareMed. 29,
196–200 (2003).
9. I. Tachtsidis, T. S. Leung, M. Tisdall, D. T. Delpy, M. Smith,
and C. E. Elwell, “Cerebral blood flow assessment with indo-
cyanine green bolus transit detection by near-infrared spec-
troscopy before and after acetazolamide provocation in
humans,” in Biomedical Optics 2006 Technical Digest (Optical
Society of America, 2006), ME67.
10. K. Zierler, “Equations for measuring blood flow by external
monitoring of radioisotopes,” Circ. Res. 16, 309–321 (1965).
11. G. T. Gobbel and J. R. Fike, “A deconvolution method for
evaluating indicator-dilution curves,” Phys. Med. Biol. 39,
1833–1854 (1994).
12. D. W. Brown, P. Picot, J. Gharavi, R. Springett, D. T. Delpy, R.
Menon, V. Han, and T. Y. Lee, “Quantitative NIRS measure-
ment of cerebral hemodynamics in newborn piglets,” Pediatr.
Res. 51, 564–570 (2002).
13. E. Keller, A. Nadler, H. Alkadhi, S. S. Kollias, Y. Yonekawa,
and P. Niederer, “Noninvasive measurement of regional cere-
bral blood flow and regional cerebral blood volume by near-
infrared spectroscopy and indocyanine green dye dilution,”
Neuroimage 20, 828–839 (2003).
14. R. D. Rothoerl, K. M. Schebesch, R. Faltermeier, C. Woertgen,
and A. Brawanski, “Lack of correlation between Xenon133 and
near-infrared spectroscopyindocyanine green rCBF measure-
ments,” Neurol. Res. 25, 528–532 (2003).
15. A. Kienle, M. S. Patterson, N. Dognitz, R. Bays, G. Wagnieres,
and H. van den Bergh, “Noninvasive determination of the
optical properties of two-layered turbid media,” Appl. Opt. 37,
779–791 (1998).
16. P. Meier and K. L. Zierler, “On the theory of the indicator-
dilution method for measurement of blood flow and volume,”
J. Appl. Physiol. 6, 731–743 (1954).
17. L. Friberg, J. Kastrup, M. Hansen, and J. Bulow, “Cerebral
effects of scalp cooling and extracerebral contribution to cal-
culated blood flow values using the intravenous 133Xe tech-
nique,” Scand. J. Clin. Lab. Invest. 46, 375–379 (1986).
18. R. M. P. Doornbos, R. Lang, M. C. Aalders, F. W. Cross, and
H. J. C. M. Sterenborg, “The determination of in vivo human
tissue optical properties and absolute chromophore concentra-
tions using spatially resolved steady-state diffuse reflectance
spectroscopy,” Phys. Med. Biol. 44, 967–981 (1999).
19. J. S. Wyatt, M. Cope, D. T. Delpy, C. E. Richardson, A. D.
Edwards, S. Wray, and E. O. Reynolds, “Quantitation of cere-
bral blood volume in human infants by near-infrared spectros-
copy,” J. Appl. Physiol. 68, 1086–1091 (1990).
20. F. Calamante, D. G. Gadian, and A. Connelly, “Delay and
dispersion effects in dynamic susceptibility contrast MRI: sim-
ulations using singular value decomposition,” Magn. Reson.
Med. 22, 466–473 (2000).
1 April 2007  Vol. 46, No. 10  APPLIED OPTICS 1613
21. R. W. Stow and P. S. Hetzel, “An empirical formula for
indicator-dilution curves as obtained in human beings,” J. Appl.
Physiol. 7, 161–167 (1954).
22. K. Murase, M. Shinohara, and Y. Yamazaki, “Accuracy of de-
convolution analysis based on singular value decomposition for
quantification of cerebral blood flow using dynamic suscepti-
bility contrast-enhanced magnetic resonance imaging,” Phys.
Med. Biol. 46, 3146–3159 (2001).
23. M. Kohl-Bareis, H. Obrig, J. Steinbrink, J. Malak, K. Uludag,
and A. Villringer, “Noninvasive monitoring of cerebral blood
flow by a dye bolus method: separation of brain from skin and
skull signals,” J. Biomed. Opt. 7, 464–470 (2002).
24. P. Mansfield, “Imaging by nuclear magnetic resonance,” J.
Phys. E 21, 18–30 (1988).
25. E. Okada and D. T. Delpy, “Near-infrared light propagation in
an adult head model. I. Modeling of low-level scattering in the
cerebrospinal fluid layer,” Appl. Opt. 42, 2906–2914 (2003).
26. M. Essenpreis, C. E. Elwell, P. van der Zee, S. R. Arridge, and
D. T. Delpy, “Spectral dependence of temporal point spread
functions in human tissues,” Appl. Opt. 32, 418–425 (1993).
27. D. M. Hueber, M. A. Franceschini, H. Y. Ma, Q. Zhang, J. R.
Ballesteros, S. Fantini, D. Wallace, V. Ntziachristos, and B.
Chance, “Noninvasive and quantitative near-infrared haemo-
globin spectrometry in the piglet brain during hypoxic stress,
using a frequency-domain multidistance instrument,” Phys.
Med. Biol. 46, 41–62 (2001).
28. Y. Hoshi, M. Shimada, C. Sato, and Y. Iguchi, “Reevaluation
of near-infrared light propagation in the adult human head:
implications for functional near-infrared spectroscopy,” J.
Biomed. Opt. 10, 064032 (2005).
29. S. J. Matcher and C. E. Cooper, “Absolute quantification of
deoxyhaemoglobin concentration in tissue near-infrared spec-
troscopy,” Phys. Med. Biol. 39, 1295–1312 (1994).
30. P. van der Zee, M. Essenpreis, and D. T. Delpy, “Optical prop-
erties of brain,” Proc. SPIE 1888, 454–465 (1993).
31. S. J. Matcher, M. Cope, and D. T. Delpy, “In vivo measure-
ments of the wavelength dependence of tissue-scattering coef-
ficients between 760 and 900 nmmeasured with time-resolved
spectroscopy,” Appl. Opt. 36, 386–396 (1997).
32. A. Duncan, J. H. Meek, M. Clemence, C. E. Elwell, P. Fallon,
L. Tyszczuk, M. Cope, and D. T. Delpy, “Measurement of
cranial optical-path length as a function of age using phase-
resolved near-infrared spectroscopy,” Pediatr. Res. 39, 889–
894 (1996).
33. M. Hiraoka, F. Firbank, M. Essenpreis, M. Cope, S. R. Arridge,
P. van der Zee, and D. T. Delpy, “A Monte Carlo investigation
of optical path length in inhomogeneous tissue and its appli-
cation to near-infrared spectroscopy,” Phys. Med. Biol. 38,
1859–1876 (1993).
34. W. H. Press, S. A. Teukolsky, W. T. Vetterling, and B. P.
Flannery, Numerical Recipes in C, 2nd ed. (Cambridge U.
Press, 1992).
35. L. Ostergaard, R. M. Weisskoff, D. A. Chesler, C. Gyldensted,
and B. R. Rosen, “High-resolution measurement of cerebral
blood flow using intravascular tracer bolus passages. Part I:
Mathematical approach and statistical analysis,” Magn. Re-
son. Med. 36, 715–725 (1996).
36. E. Keller, M. Wolf, M. Martin, and Y. Yonekawa, “Estimation
of cerebral oxygenation and hemodynamics in cerebral vaso-
spasm using indocyanine green dye dilution and near-infrared
spectroscopy,” J. Neurosurg. Anesthesiol. 13, 43–48 (2001).
37. A. Liebert, H. Wabnitz, J. Steinbrink, M. Moller, R. Mac-
donald, H. Rinneberg, A. Villringer, and H. Obrig, “Bedside
assessment of cerebral perfusion in stroke patients based on
optical monitoring of a dye bolus by time-resolved diffuse re-
flectance,” Neuroimage 24, 426–435 (2005).
38. L. Ostergaard, D. A. Chesler, R. M. Weisskoff, A. G. Sorensen,
and B. R. Rosen, “Modeling cerebral blood flow and flow het-
erogeneity from magnetic resonance residue data,” J. Cereb.
Blood Flow Metab. 19, 690–699 (1999).
1614 APPLIED OPTICS  Vol. 46, No. 10  1 April 2007
